Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers

Psychiatry Research

Volumn 64, Issue 1, 1996, Pages 1-10

  Grady, Tana A ^a   Broocks, Andreas ^b   Canter, Stephanie K ^c   Pigott, Teresa A ^d   Dubbert, Billinda ^e   Hill, James L ^f   Murphy, Dennis L ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

5 Hydroxytryptamine; Blood pressure; Cortisol; Dopamine; Growth hormone; Mood; Prolactin; Temperature

Indexed keywords

AMPHETAMINE; COCAINE; DEXAMPHETAMINE; GROWTH HORMONE; ONDANSETRON; PLACEBO; PROLACTIN; SEROTONIN 3 RECEPTOR;

ADULT; ANXIETY; ARTICLE; BEHAVIOR; BLOOD PRESSURE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUPHORIA; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030606903     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02884-3     Document Type: Article

References (47)

1. Angrist, B., Corwin, J., Bartlik, B. and Cooper, T. (1987). Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biol Psychiatry 22, 1357-1368.
2. 3 receptor in mammalian brain: A new target for the development of psychotropic drugs? Neuropsychopharmacology 8, 117-130.
3. Blackwell, C.P. and Harding, S.M. (1989) The clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 25(Suppl. 1), S71-S74.
4. 3 receptors in rat striatum. J Pharmacol Exp Ther 251, 803-809.
5. Broocks, A., Briggs, N.C., Pigott, T.A., Canter, S.K., Tolliver, T.J., Baldemore, D. and Murphy, D.L. (1996) Physiological and behavioral neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment. Psychopharmacology, in press.
6. Brown, W.A., Corriveau, D.P. and Ebert, M.H. (1978) Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacology 58, 189-195.
7. 3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 164, 515-519.
8. 3 receptor by l-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Eur J Pharmacol 164, 515-519.
9. 3 Receptors. Academic Press, London, pp. 19-28.
10. 3 receptors in the central nervous system. Br J Pharmacol 90, 89P.
11. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92, 881-894.
12. 3 receptors. Pharmacol Toxicol 71, 401-415.
13. 3 receptors. Pharmacol Ther 47, 181-202.
14. Creese, I. and Iversen, S.D. (1972) Amphetamine response in rat after dopamine neuron destruction. Nature 238, 247-248.
15. Cubbedu, L.X., Hoffmann, I.S., Fuenmayor, N.T. and Finn, A.L. (1990) Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322, 810-816.
16. Derogatis, L.R. (1977) SCL-90: Administration, Scoring and Procedures Manual-I for the Revised Version. Johns Hopkins University School of Medicine, Baltimore, MD.
17. Dommisse, C.S., Schulz, S.C., Narasimhachari, N., Blackard, W.G. and Hamer, R.M. (1984) The neuroendocrine and behavioral response to dextroamphetamine in normal individuals. Biol Psychiatry 19, 1305-1315.
18. Ellinwood, E.H. and Kilbey, M.M. (1975) Species differences in response to amphetamine. In: Eleftheriou, B.E. (Ed.), Psychopharmacogenetics. Plenum Press, New York, pp. 324-375.
19. Feuerstein, T.J. and Hertting, G. (1986) Serotonin (5-HT) enhances hippocampal noradrenaline release: Evidence for facilatory 5-HT receptors within the CNS. Naunyn-Schmiedebergs Arch Pharmacol 333, 191-197.
20. 3 receptors in drug dependence. Drug Alcohol Depend 38, 155-171.
21. Hall, S.T. and Ceuppens, P.R. (1991) A study to evaluate the effect of ondansetron on psychomotor performance after repeated oral dosing in healthy subjects. Psychopharmacology 104, 86-90.
22. 3 antagonist ondansetron (O) for cocaine (C)-like activity and abuse potential. NIDA Res Monogr 105, 515.
23. 3 receptor blockade: A preliminary study in healthy male volunteers. Psychopharmacology 112, 142-144.
24. Jonsson, L.E., Ånggard, E. and Gunne, L.M. (1971) Blockade of intravenous amphetamine euphoria in man. Clin Pharmacol Ther 12, 889-896.
25. 3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Neuroendocrinology 55, 336-343.
26. Kelly, P.H., Seviour, P.W. and Iversen, S.D. (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94, 507-522.
27. Knych, E.T. and Eisenberg, R.M. (1980) Effect of fluoxetine and metergoline on amphetamine-induced rise in plasma corticosterone. Life Sci 26, 1489-1496.
28. 3 Antagonist, in the Treatment of Psychiatric Disorders. Proceedings of the Fifth World Congress of Biological Psychiatry, Florence, Italy (Gardiner-Caldwell Communications Ltd.), pp. 17-19.
29. Layer, R.T., Uretsky, N.J. and Wallace, L.J. (1992) Effect of serotonergic agonists in the nucleus accumbens on D-amphetamine-stimulated locomotion. Life Sci 50, 813-820.
30. 3 receptors in the secretion of prolactin, ACTH and renin. Neuroendocrinology 58, 65-70.
31. Lurie, S. and O'Quinn, A. (1991) Neuroendocrine responses to methylphenidate and D-amphetamine: Applications to attention deficit disorder. J Neuropsychiatry Clin Sci 3, 41-50.
32. 3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens. Pharmacol Biochem Behav 45, 759-763.
33. 3 receptor antagonists on the discriminative stimulus effects of amphetamine. Eur J Pharmacol 212, 271-274.
34. Murphy, D.L., Mueller, E.A., Hill, J.L., Tolliver, T.J. and Jacobsen, F.M. (1989) Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology 98, 275-282.
35. Nielsen, E.B. and Jepsen, S.A. (1985) Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. Eur J Pharmacol 11, 167-176.
36. 3 antagonists: Recent advances. Prog Med Chem 29, 239-270.
37. Pijnenburg, A.J. and van Rossum, J.M. (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25, 1003-1005.
38. Randrup, A. and Munkvad, I. (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11, 300-310.
39. 3H] dopamine. Eur J Pharmacol 167, 309-310.
40. Segal, D.S. and Schuckit, M.A. (1983) Animal models of stimulant-induced psychosis. In: Creese, I. (Ed.), Stimulants: Neurochemical, Behavioral and Clinical Perspectives. Raven Press, New York, pp. 131-167.
41. Seiden, L.S. and Sabol, K.E. (1993) Amphetamine: Effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32, 639-677.
42. Silverstone, P.H., Johnson, B. and Cowen, P.J. (1992a) Does ondansetron attenuate amphetamine-induced behaviour in human volunteers? Psychopharmacology 107, 140-141.
43. 3 receptor antagonist, partially attenuates the effects of amphetamine: A pilot study in healthy volunteers. Int Clin Psychopharmacol 7, 37-43.
44. Swerdlow, N.R., Koob, G.F., Cador, M., Lorang, M. and Hauger, R.L. (1993) Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav 45, 629-637.
45. 3 Receptors. Academic Press, London, pp. 190-205.
46. van Kammen, D.P. and Murphy, D.L. (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44, 215-224.
47. Warburton, E.C., Joseph, M.H., Feldon, J., Weiner, I. and Gray, J.A. (1994) Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: Implications for a possible antipsychotic action of ondansetron. Psychopharmacology 114, 657-664.